An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

Lilly’s upfront offer for Adverum, the developer of a gene therapy for age-related macular degeneration, is less than the ...

Children with hereditary deafness regained their hearing thanks to a type of gene therapy, a new study published on Wednesday found. In a clinical trial, co-led by investigators from Mass Eye and Ear, ...

However, in late September 2025, scientists successfully treated Huntington’s for the first time in a ground-breaking study.

The novel treatment, partly developed by CHOP, eliminates the need for regular infusions while preventing the ...

Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...

Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

Eli Lilly ($LLY) is strengthening its presence in genetic medicine with a deal worth $261.7 million to acquire Adverum ...

Intellia Therapeutics (NASDAQ:NTLA) shares plummeted 50% on Monday after the company announced a temporary halt to patient ...

When she was born, doctors informed Opal Sandy’s parents that their child would never hear. At the age of 11 months, she had ...